Moderna Reaffirms Commitment to Job Creation in Massachusetts

Company recently announced expansion of the Moderna Technology Center in Norwood, MA

Company has nearly doubled the size of its workforce since March 31, 2020 and continues to grow

Company commits to hiring at least 155 new Massachusetts-based employees for high-tech manufacturing positions in 2021 and retaining through 2025

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reaffirmed its commitment to job creation in Massachusetts. Over the last year, Moderna nearly doubled the size of its workforce, from approximately 830 employees as of March 31, 2020 to approximately 1,500 employees as of March 31, 2021. In the last year, Moderna created more than 650 new jobs at its manufacturing facility in Norwood, Massachusetts. The Company continues to expand in Norwood and Cambridge.

On June 15, Moderna was awarded a tax incentive from the Massachusetts Life Sciences Center (MLSC) based on its commitment to hire 155 new full-time equivalent employees in 2021 and retaining that headcount through 2025. The MLSC Tax Incentive Program awards companies engaged in life science research and development, commercialization and manufacturing with the goal of creating new, long-term jobs in the state of Massachusetts.

“I would like to thank the Massachusetts Life Sciences Center and the Baker-Polito Administration for this recognition of our commitment to creating new, high-tech employment opportunities in Massachusetts. We have been based in the Commonwealth since our founding more than 10 years ago and we opened our manufacturing facility in Norwood in 2018. This facility has been integral to our long-term strategy and helped anchor our manufacturing capacity as we worked relentlessly to combat the COVID-19 pandemic,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Massachusetts continues to be the global leader in the biotech industry and having our manufacturing facility in Norwood has enabled close collaboration with our research and development teams in Cambridge. It’s also allowed us to work with state and local partners and to leverage the incredible innovation and diverse talent from the Massachusetts life sciences and technology sectors. We are proud to create new biotech and manufacturing jobs in Massachusetts as we work to develop new mRNA medicines.”

Moderna recently announced an expansion of the Moderna Technology Center in Norwood, including more than doubling of space to transform the facility from a production and lab space to an industrial technology center. This expansion includes increasing the Company’s production and lab space from approximately 300,000 square feet to approximately 650,000 square feet through renovation of existing space and entering into a long-term lease of a 240,000 square foot building located on the same campus for expansion of its commercial and clinical activities. The expansion also includes an increase in Moderna’s technical development capacity and preclinical production capability.

The Company’s expansion in Norwood will support a 50% increase in production of the Moderna COVID-19 Vaccine from its manufacturing site, which is expected to ramp up in late 2021 and early 2022. On April 29, Moderna announced an investment at its owned and partnered manufacturing facilities that it expects will increase 2022 global capacity to up to 3 billion doses of its COVID-19 vaccine, depending upon the mix between the authorized Moderna COVID-19 Vaccine at the 100 μg dose level and potentially lower doses of the Company’s variant booster candidates and pediatric vaccines, if authorized.

Moderna opened its Norwood manufacturing site in July 2018. Digital technology is integrated throughout the site—the entire research, development and production process incorporates advanced robotics, machine learning, artificial intelligence and creative design. Designed to Current Good Manufacturing Practices (cGMP), this expansion gives the Company the capacity and flexibility to support the manufacture of the Company’s commercial COVID-19 vaccine and the other programs in Moderna’s clinical development pipeline. In addition, the site was built with attention to environmental sustainability and to qualify for LEED certification.

About Moderna

In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.

Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 14 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the Company’s development of a vaccine to protect against the SARS-CoV-2 virus (mRNA-1273, also referred to as the Moderna COVID-19 Vaccine); anticipated production of the Moderna COVID-19 Vaccine in 2021 and 2022; and the Company’s hiring and employment plans within the state of Massachusetts. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include those other risks and uncertainties described under the heading “Risk Factors” in Moderna’s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date hereof.

Contacts

Media:
Colleen Hussey

Director, Corporate Communications

617-335-1374

[email protected]

Investors:
Lavina Talukdar

Senior Vice President & Head of Investor Relations

617-209-5834

[email protected]

A Few Current Job Opening as of June 6, 2021 on the OutBüro Career Center


Discover hundreds of exciting professional opportunities available on OutBüro Career Center
OUTBURO
Multi-Discipline Building Inspector
Illinois
T.P.I. Building Code Consultants – View Job
Police Officer (certified)
Williamston, South Carolina
Williamston Police Department – View Job
Interventional Radiologist
Lowell, Massachusetts
Commonwealth Radiology Associates – View Job
Certified Police Officer
Hollywood, Florida
City of Hollywood – View Job
Non-Certified Police Officer
Hollywood, Florida
City of Hollywood – View Job
Family Medicine Physician in SW Florida – New Grads Welcome!
Fort Myers, Florida
Physicians’ Primary Care – View Job
REI Physician – SIGN ON BONUS AVAILABLE
Jacksonville, Florida
Florida Institute for Reproductive Medicine – View Job
Endocrinologist
Illinois
NorthShore University HealthSystem – View Job
Associate Attorney
Palm Beach Gardens, Florida
Bobo Ciotoli White & Russell, P.A. – View Job
Now offering in-basket support for primary care providers!
Bellevue, Washington
Overlake Medical Center – View Job
Correctional Officer
Tallahassee, Florida
Leon County Sheriff’s Office – View Job
Clinical Research Coordinator II-III
SEATTLE, Washington
Benaroya Research Institute at Virginia Mason – View Job
Family Nurse Practitioner or Physician Assistant
Peoria, Arizona
Trident Health Center – View Job
Academic Pediatric Radiologist with Abdominal Imaging experience
Pittsburgh, Pennsylvania
UPMC, Department of Radiology – View Job
School Crossing Guard
Florida
Orange County Sheriff’s Office – View Job
Nephrologist – Well-established practice
Kansas City, Missouri
Kidney Associates of Kansas City – View Job
Duke Primary Care – Join A Growing Network
Raleigh, North Carolina
Duke Primary CareView Job
MULTIPLE POSITIONS AVAILABLE
Little Rock, Arkansas
The Department of Psychiatry at the University of Arkansas for Medical Sciences (UAMS) – View Job
Physiotherapist
McLaren Vale, South Australia (SA
Physio Alive – View Job
Associate Attorney
Atlanta, Georgia
Carlock, Copeland & Stair, LLP – View Job 

View All Jobs Remember to update your resume on OutBüro Career Center, so employers can contact you about new job opportunities.

Siemens Launches “Where the Jobs Are” Series to Highlight Open Positions and Career Pathways for the Next Generation of Skilled Workers

With more than 2,000 open jobs across the country and continued investment in apprenticeships and training initiatives, Siemens is committed to bringing Americans back into the workforce

WASHINGTON–(BUSINESS WIRE)–At the 8th annual SelectUSA Investment Summit, Siemens announced the launch of its Where the Jobs Are 2021 series to highlight the company’s training and career opportunities across the country. With more than 2,000 job openings in the U.S., Siemens is investing in advanced workforce development, training, and apprenticeship programs, as well as deepening its commitment to economic, social and racial justice in the United States.

Each month, Siemens will feature open positions in its business units and training initiatives available through partnerships with universities, community colleges, technical and trade schools across the country. Siemens first launched its Where the Jobs Are series in 2011 at a time when 14 million Americans were out of work two years after the recession. In support of bringing Americans back into the post-pandemic workforce, Siemens is relaunching the initiative to bring awareness and access to opportunities and demand for high-skill, high wage jobs.

“Our company’s success rests on skilled workers around the world – not just within our own company, but also among our suppliers and customers,” said Barbara Humpton, president and CEO of Siemens USA. “Now, more than ever, the country needs an inclusive workforce development agenda that brings more people into the process and doesn’t leave anyone behind —because when everyone has the opportunity to thrive, we all succeed.”

Across the country, there is an urgent and growing need to fill skilled trades jobs, or roles that require specialized knowledge and training gained through a technical school, an apprenticeship, or on the job. At Siemens, skilled trade jobs account for 32 percent of its entire hiring demand, with open positions primarily in its manufacturing facilities in Sacramento, California, Roebuck/Spartanburg, South Carolina., Southaven, Mississippi, and Grand Prairie, Texas. To help fill skilled trade roles for both Siemens and its customers, the company partners with community and technical schools to help inform curriculum, provide hardware and software grants, and collaborate on certifications like mechatronics to prepare skilled workers to secure a high-paying job without the need of a four-year degree. To view related open positions, interested candidates can visit www.usa.siemens.com/careers.

Each year, Siemens invests $37 million in workforce training and champions apprenticeship programs that prepare and connect more young people for the jobs that industry, and the economy, need. Last month, Siemens announced an expansion of its Spartanburg, South Carolina plant, supporting the creation of more than 180 new jobs and stood up a new apprenticeship program in partnership with a local community college to support the skilled work being done at the facility.

The Siemens Foundation, a non-profit organization established by Siemens, has invested more than $130 million in the United States to advance workforce development and education initiatives in science, technology and math (STEM), which is inspired by the culture of innovation, research and continuous learning that is the hallmark of Siemens’ companies. Most recently, the Siemens Foundation partnered with the Association of Controls Professionals (ACP) to invest in a workforce training program and an industry-recognized, nonproprietary certification for building controls professionals that will be available later this year.

To follow the Siemens Where the Jobs Are Series, you can visit www.usa.siemens.com/wherethejobsare and all open positions in the United States can be found at www.usa.siemens.com/careers

Siemens Corporation is a U.S. subsidiary of Siemens AG, a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 170 years. Active around the world, the company focuses on intelligent infrastructure for buildings and distributed energy systems and on automation and digitalization in the process and manufacturing industries. Siemens brings together the digital and physical worlds to benefit customers and society. Through Mobility, a leading supplier of intelligent mobility solutions for rail and road transport, Siemens is helping to shape the world market for passenger and freight services. Via its majority stake in the publicly listed company Siemens Healthineers, Siemens is also a world-leading supplier of medical technology and digital health services. In addition, Siemens holds a minority stake in Siemens Energy, a global leader in the transmission and generation of electrical power that has been listed on the stock exchange since September 28, 2020. In fiscal 2020, Siemens Group USA generated revenue of $17 billion and employs approximately 40,000 people serving customers in all 50 states and Puerto Rico.

Contacts

Contact for journalists

Caroline Cassidy

Phone: (770) 826-7379; E-mail: [email protected]